Log in or Sign up for Free to view tailored content for your specialty!
Hepatology News
Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease
Researchers recommended that patients with steatotic liver disease who are at a lower risk for advanced cirrhosis should consume no more than 7.4 grams of alcohol per day, the equivalent of a half a 12 oz. beer or half a glass of wine.
VIDEO: Interim INTEGRIS-PSC trial results ‘promising’ in primary sclerosing cholangitis
BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about interim results from the phase 2a INTEGRIS-PSC trial presented at The Liver Meeting, which showed bexotegrast reduced biomarkers of liver fibrosis vs. placebo.
Log in or Sign up for Free to view tailored content for your specialty!
A ‘hidden practice’: Senior physicians see fewer underrepresented patients
Senior physicians cared for fewer patients in underrepresented racial and ethnic groups as well as those with Medicaid compared with their junior colleagues within the same practice, a study published in JAMA Network Open found.
VIDEO: Preclinical research investigates role of Claudin-1 in cholangiocarcinoma
BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about research assessing the role of Claudin-1 in cholangiocarcinoma, which was presented at The Liver Meeting.
Liver transplant rates for HCC decline across all races after 2015 MELD policy change
Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.
VIDEO: ‘Unique’ protocol expands transplant pool to include HCV-infected donors
BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, spoke with Healio about a presentation from The Liver Meeting on “The Toronto Protocol,” an ultra-short course of glecaprevir/pibrentasvir with ezetimibe.
VIDEO: Prevalence of HCV has not changed since 2013-2016 estimate
BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses findings from an abstract at The Liver Meeting, which estimated the prevalence of hepatitis C virus infection in the United States between 2017 and 2020.
VIDEO: Treating HCV in pregnancy may reduce risk for mother-to-child transmission
BOSTON — Healio spoke with Norah Terrault, MD, MPH, FAASLD, about presentations from The Liver Meeting that investigated testing and treatment of hepatitis C virus infection among pregnant individuals.
Year-end portfolio checklist: Proactive planning can reduce taxes on investments
As we approach the year end, many investors, including physicians, will review their portfolios and assess the last 12 months of performance.
Point-of-diagnosis HCV treatment model yields 95% SVR at 12 weeks among marginalized group
A test-and-treat model for hepatitis C virus infection among injection drug users and people experiencing homelessness resulted in high levels of treatment initiation, completion and cure, and may expand care access to marginalized groups.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read